Neurodevelopmental Outcomes of the Child with Congenital Heart Disease

Beatrice Latal1

  • 1Child Development Center, University Children's Hospital Zurich, Steinwiesstrasse 75, Zurich 8032, Switzerland.

Clinics in Perinatology
|February 16, 2016
PubMed

Insights

Children surviving congenital heart disease (CHD) surgery face higher risks of developmental delays. Early neurodevelopmental assessments are crucial for identifying and managing these noncardiac issues in infants and neonates.

Area of Science:

  • Pediatric Cardiology
  • Neurodevelopmental Pediatrics
  • Congenital Heart Disease Research

Background:

  • Survival rates for infants and neonates undergoing bypass surgery for moderate to severe congenital heart disease (CHD) have significantly improved.
  • While cardiac outcomes are often favorable, a substantial proportion of these children experience developmental impairments across various domains.
  • Identifying risk factors is essential for proactive intervention and support.

Purpose of the Study:

  • To highlight the increased risk of noncardiac developmental impairments in children surviving congenital heart disease (CHD) surgery.
  • To inform healthcare providers, patients, and parents about these potential sequelae.
  • To advocate for the establishment of neurodevelopmental follow-up programs in tertiary centers.

Main Methods:

  • Review of existing literature on developmental outcomes in pediatric patients with congenital heart disease (CHD).
  • Analysis of identified risk factors associated with neurodevelopmental impairments.
  • Emphasis on the importance of structured neurodevelopmental assessments.

Main Results:

  • Children with congenital heart disease (CHD) are at a heightened risk for developmental impairments, affecting cognitive, motor, and language skills.
  • Key risk factors include genetic disorders, preterm birth, prolonged intensive care unit (ICU) stays, socioeconomic factors, and CHD complexity.
  • Early and regular neurodevelopmental assessments are vital for detecting issues.

Conclusions:

  • Improved survival in congenital heart disease (CHD) necessitates a focus on noncardiac outcomes, particularly neurodevelopmental health.
  • Tertiary centers performing open-heart surgery should implement comprehensive neurodevelopmental follow-up programs.
  • Proactive identification and management of developmental problems are critical for optimizing long-term quality of life for these children.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
671
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.2K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.5K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
743
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.2K